Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07584109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Value Clarification Based on Meleis's Transition Theory on Menopausal Symptoms, Depression, Anxiety, Stress, and Quality of Life in Perimenopausal Women

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 13, 2026 (before its estimated August 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Ordu University
30 trials monitored
See 1 trial at risk
Anxiety
3,263 trials monitored
See 159 trials at risk
Menopause is a life stage influenced not only by hormonal factors but also by psychological, social, and cultural factors. Symptoms such as hot flashes, sleep problems, and mood changes may occur, and their severity depends on how a woman perceives and copes with this period. The study aims to examine the effects of the "Value Clarification" method based on Meleis Transition Theory on menopausal symptoms, depression, anxiety, stress, and quality of life in women during menopause.
Trial Details
NCT Number NCT07584109
Lead Sponsor Ordu University
Conditions
(from sponsor)		 Menopausal Women
Related terms Anxiety Disorders, Depression
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov